Menéndez-Valle, I.; Cachán-Vega, C.; Boga, J.A.; González-Blanco, L.; Antuña, E.; Potes, Y.; Caballero, B.; Vega-Naredo, I.; Saiz, P.; Bobes, J.;
et al. Differential Cellular Interactome in Schizophrenia and Bipolar Disorder—Discriminatory Biomarker Role. Antioxidants 2023, 12, 1948.
https://doi.org/10.3390/antiox12111948
AMA Style
Menéndez-Valle I, Cachán-Vega C, Boga JA, González-Blanco L, Antuña E, Potes Y, Caballero B, Vega-Naredo I, Saiz P, Bobes J,
et al. Differential Cellular Interactome in Schizophrenia and Bipolar Disorder—Discriminatory Biomarker Role. Antioxidants. 2023; 12(11):1948.
https://doi.org/10.3390/antiox12111948
Chicago/Turabian Style
Menéndez-Valle, Iván, Cristina Cachán-Vega, José Antonio Boga, Laura González-Blanco, Eduardo Antuña, Yaiza Potes, Beatriz Caballero, Ignacio Vega-Naredo, Pilar Saiz, Julio Bobes,
and et al. 2023. "Differential Cellular Interactome in Schizophrenia and Bipolar Disorder—Discriminatory Biomarker Role" Antioxidants 12, no. 11: 1948.
https://doi.org/10.3390/antiox12111948
APA Style
Menéndez-Valle, I., Cachán-Vega, C., Boga, J. A., González-Blanco, L., Antuña, E., Potes, Y., Caballero, B., Vega-Naredo, I., Saiz, P., Bobes, J., García-Portilla, P., & Coto-Montes, A.
(2023). Differential Cellular Interactome in Schizophrenia and Bipolar Disorder—Discriminatory Biomarker Role. Antioxidants, 12(11), 1948.
https://doi.org/10.3390/antiox12111948
